These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 22356677)
1. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival. Slipicevic A; Holm R; Emilsen E; Ree Rosnes AK; Welch DR; Mælandsmo GM; Flørenes VA BMC Cancer; 2012 Feb; 12():73. PubMed ID: 22356677 [TBL] [Abstract][Full Text] [Related]
2. The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells. Slipicevic A; Jørgensen K; Skrede M; Rosnes AK; Trøen G; Davidson B; Flørenes VA BMC Cancer; 2008 Sep; 8():276. PubMed ID: 18826602 [TBL] [Abstract][Full Text] [Related]
3. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis. Li J; Cheng Y; Tai D; Martinka M; Welch DR; Li G Oncogene; 2011 Feb; 30(8):896-906. PubMed ID: 20935672 [TBL] [Abstract][Full Text] [Related]
5. Location, location, location: the BRMS1 protein and melanoma progression. Riker AI; Samant RS BMC Med; 2012 Feb; 10():19. PubMed ID: 22356729 [TBL] [Abstract][Full Text] [Related]
6. Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma. Jørgensen K; Davidson B; Flørenes VA Mod Pathol; 2006 Nov; 19(11):1446-55. PubMed ID: 16951673 [TBL] [Abstract][Full Text] [Related]
7. The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions. Pilloni L; Bianco P; Difelice E; Cabras S; Castellanos ME; Atzori L; Ferreli C; Mulas P; Nemolato S; Faa G Eur J Histochem; 2011 Jun; 55(2):e20. PubMed ID: 22193299 [TBL] [Abstract][Full Text] [Related]
8. High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi. Chin SY; Wu PR; Shih YH; Yeh CM; Lee WR; Shen SC; Yeh KT; Jiang MC; Tseng JT Int J Clin Exp Pathol; 2015; 8(2):1393-401. PubMed ID: 25973023 [TBL] [Abstract][Full Text] [Related]
9. A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers. Frolova N; Edmonds MD; Bodenstine TM; Seitz R; Johnson MR; Feng R; Welch DR; Frost AR Tumour Biol; 2009; 30(3):148-59. PubMed ID: 19609101 [TBL] [Abstract][Full Text] [Related]
10. Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand. Zhuang L; Lee CS; Scolyer RA; McCarthy SW; Zhang XD; Thompson JF; Screaton G; Hersey P Hum Pathol; 2006 Oct; 37(10):1286-94. PubMed ID: 16949935 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of cytoplasmic p27 expression in human melanoma. Chen G; Cheng Y; Zhang Z; Martinka M; Li G Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232 [TBL] [Abstract][Full Text] [Related]
12. Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival. Flørenes VA; Maelandsmo GM; Kerbel RS; Slingerland JM; Nesland JM; Holm R Am J Pathol; 1998 Jul; 153(1):305-12. PubMed ID: 9665492 [TBL] [Abstract][Full Text] [Related]
13. WT 1 expression in nevi and melanomas: a marker of melanocytic invasion into the dermis. Garrido-Ruiz MC; Rodriguez-Pinilla SM; Pérez-Gómez B; Rodriguez-Peralto JL J Cutan Pathol; 2010 May; 37(5):542-8. PubMed ID: 19638168 [TBL] [Abstract][Full Text] [Related]
14. Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions. Rothberg BE; Moeder CB; Kluger H; Halaban R; Elder DE; Murphy GF; Lazar A; Prieto V; Duncan LM; Rimm DL Mod Pathol; 2008 Sep; 21(9):1121-9. PubMed ID: 18552823 [TBL] [Abstract][Full Text] [Related]
15. Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma. Flørenes VA; Emilsen E; Dong HP; Førsund M; Holm R; Slipicevic A Cancer Med; 2015 Jun; 4(6):903-13. PubMed ID: 25663244 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases. Dai DL; Martinka M; Li G J Clin Oncol; 2005 Mar; 23(7):1473-82. PubMed ID: 15735123 [TBL] [Abstract][Full Text] [Related]
17. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. Zhang S; Lin QD; DI W Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721 [TBL] [Abstract][Full Text] [Related]